Lab
HPM Foundation INC
HPM Foundation INC was paid $2.71M by Medicaid between Nov 2018 and Dec 2024, across 80 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 13% of everything it billed.
33Billing provider infoHPM FOUNDATION INC
SAN JUAN, PR 00915
SAN JUAN, PR 00915
33aNPI1417359142assigned 09/25/2014
33bProvider typeClinical Medical Laboratory
28Total paid$2.71M
24GClaims200,063
24DCodes billed80
24AFirst – last monthNov 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#28 of 777
Median peer was paid$278K
This provider vs. median9.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 397 | $3K | |
| 2019 | 16,126 | $109K | |
| 2020 | 23,500 | $343K | |
| 2021 | 39,474 | $624K | |
| 2022 | 31,471 | $510K | |
| 2023 | 34,617 | $378K | |
| 2024incomplete | 54,478 | $742K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 6,903 | 6,212 | $339K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.6% | 6,397 | 5,491 | $206K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.4% | 6,539 | 5,613 | $201K |
| 80061 | Lipid panel | 6.9% | 16,014 | 13,609 | $187K |
| 84443 | Thyroid stimulating hormone (TSH) | 6.9% | 13,574 | 11,638 | $187K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.9% | 6,789 | 6,209 | $160K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.8% | 24,106 | 20,245 | $156K |
| 80074 | 5.7% | 3,484 | 2,897 | $153K | |
| 80053 | Comprehensive metabolic panel | 5.6% | 17,097 | 14,514 | $151K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.8% | 5,280 | 4,333 | $103K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.6% | 12,012 | 10,167 | $98K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.4% | 2,381 | 1,955 | $93K |
68 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.1% | 4,094 | $84K |
| 82274 | 3.0% | 5,792 | $82K | |
| 84439 | 2.5% | 8,216 | $67K | |
| 81000 | 1.8% | 17,744 | $50K | |
| 86738 | 1.1% | 2,464 | $31K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 2,611 | $28K |
| 87276 | <1% | 2,363 | $26K | |
| 87275 | <1% | 2,371 | $26K | |
| 84153 | <1% | 1,573 | $25K | |
| 86592 | <1% | 6,459 | $24K | |
| 82607 | <1% | 1,725 | $23K | |
| 86701 | <1% | 2,569 | $22K | |
| 87088 | <1% | 2,340 | $17K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,140 | $16K |
| 82043 | <1% | 1,921 | $11K | |
| 86803 | <1% | 778 | $10K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 187 | $9K |
| 83655 | <1% | 799 | $9K | |
| 87581 | <1% | 294 | $8K | |
| 86328 | <1% | 446 | $8K | |
| 82570 | <1% | 1,603 | $8K | |
| 86849 | <1% | 357 | $7K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 221 | $7K |
| 85730 | <1% | 1,243 | $7K | |
| 80050 | General health panel | <1% | 726 | $7K |
| 82728 | <1% | 387 | $5K | |
| 85610 | <1% | 1,227 | $4K | |
| 84702 | <1% | 292 | $4K | |
| 87807 | <1% | 377 | $4K | |
| 87340 | <1% | 384 | $4K | |
| 83001 | <1% | 190 | $3K | |
| 84436 | <1% | 625 | $3K | |
| 83002 | <1% | 189 | $3K | |
| 86710 | <1% | 120 | $3K | |
| 87536 | <1% | 41 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 527 | $3K |
| 85651 | <1% | 821 | $3K | |
| 87390 | <1% | 211 | $2K | |
| 84146 | <1% | 117 | $2K | |
| 84156 | <1% | 633 | $2K | |
| 84703 | <1% | 313 | $2K | |
| 86702 | <1% | 211 | $2K | |
| 83540 | <1% | 191 | $1K | |
| 87177 | <1% | 207 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 137 | $1K |
| 86038 | <1% | 96 | $1K | |
| 84403 | <1% | 40 | $995.29 | |
| 82947 | <1% | 328 | $957.78 | |
| 83550 | <1% | 99 | $794.93 | |
| 87338 | <1% | 65 | $642.52 | |
| 86360 | <1% | 15 | $604.04 | |
| 86141 | <1% | 101 | $544.13 | |
| 82105 | <1% | 57 | $502.87 | |
| 86703 | <1% | 32 | $364.79 | |
| 86431 | <1% | 43 | $224.44 | |
| 82950 | <1% | 46 | $210.83 | |
| 84479 | <1% | 48 | $209.78 | |
| 86140 | <1% | 44 | $199.23 | |
| 82746 | <1% | 15 | $163.03 | |
| 80076 | <1% | 31 | $134.63 | |
| 82951 | <1% | 42 | $91.36 | |
| 85027 | <1% | 15 | $88.93 | |
| 84520 | <1% | 21 | $79.04 | |
| 84550 | <1% | 13 | $52.01 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 12 | $15.90 |
| 3051F | 0% | 15 | $0.00 | |
| 3048F | 0% | 44 | $0.00 | |
| 3049F | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIVERA, IVONNE (CEO)
| Provider | Location | Paid |
|---|---|---|
| HPM Foundation INC | San Juan, PR | $2.76M |
| HPM Foundation INC Centro De Imagen | San Juan, PR | $671K |
| HPM Foundation Clinical Laboratory | Vieques, PR | $18K |
| HPM Foundation INC | Guaynabo, PR | $11K |
| HPM Foundation INC | San Juan, PR | $1K |
| HPM Foundation INC | Carolina, PR | $508.71 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.